Caristo Diagnostics Limited
Caristo Diagnostics specializes in AI-powered technology for detecting coronary inflammation and atherosclerosis through cardiac CT scans. Their innovative CaRi-Heart technology helps cardiologists identify at-risk patients by measuring inflammation, ultimately guiding personalized patient management.
Founded: 22 Jun 2018
Industries:
86220 - Specialists medical practice activities
Website: caristo.com
Phone: +441865950720
Email: eu_privacy@caristo.com
Location: Oxford
Products & Services
• ai-powered cardiac risk assessment
• ai technology
• atherosclerosis
• cardiac ct
• cari-heart® technology
• coronary inflammation
• heart disease
• image analysis for coronary artery inflammation
• software company
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
8
Shareholders
42
Controllers (PSC)
4
Keith Michael Channon
Director • British • Lives in United Kingdom • Born in Nov 1963
Charalambos Antoniades
Director • Cypriot • Lives in United Kingdom • Born in Jul 1974
Timothy Shan Rea
Director • British • Lives in United Kingdom • Born in Mar 1967
Stefan Neubauer
Director • German,british • Lives in England • Born in Sept 1959
Liliane Chamas
Director • British,canadian • Lives in United Kingdom • Born in Oct 1986
Registered Office Address
New Barclay House
234 Botley Road
Oxford
OX2 0HP
United Kingdom
Basic Information
LTD
22 Jun 2018
ENGLAND WALES
Yes
Industry Classification
86220
Company Attributes
N/A
N/A
N/A
N/A
Summary
15
Officers
4
PSCs
0
Filings